Global Communicable Diseases Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: G45ABDB47D12EN
QYResearch

Abstracts

This report focuses on the global Communicable Diseases Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Communicable Diseases Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis
• Gilead
• GSK
• Janssen Pharmaceutical
• Roche
• BioCryst Pharmaceuticals
• Merck
• Boehringer Ingelheim

Market segment by Type, the product can be split into

• HIV
• Influenza
• TB
• Malaria
• Hepatitis
• HPV

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Communicable Diseases Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Communicable Diseases Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Communicable Diseases Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Communicable Diseases Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Communicable Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HIV
  1.4.3 Influenza
  1.4.4 TB
  1.4.5 Malaria
  1.4.6 Hepatitis
  1.4.7 HPV
1.5 Market by Application
  1.5.1 Global Communicable Diseases Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Communicable Diseases Treatment Market Perspective (2015-2026)
2.2 Communicable Diseases Treatment Growth Trends by Regions
  2.2.1 Communicable Diseases Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Communicable Diseases Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Communicable Diseases Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Communicable Diseases Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Communicable Diseases Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Communicable Diseases Treatment Players by Market Size
  3.1.1 Global Top Communicable Diseases Treatment Players by Revenue (2015-2020)
  3.1.2 Global Communicable Diseases Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Communicable Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Communicable Diseases Treatment Market Concentration Ratio
  3.2.1 Global Communicable Diseases Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Communicable Diseases Treatment Revenue in 2019
3.3 Communicable Diseases Treatment Key Players Head office and Area Served
3.4 Key Players Communicable Diseases Treatment Product Solution and Service
3.5 Date of Enter into Communicable Diseases Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Communicable Diseases Treatment Historic Market Size by Type (2015-2020)
4.2 Global Communicable Diseases Treatment Forecasted Market Size by Type (2021-2026)

5 COMMUNICABLE DISEASES TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Communicable Diseases Treatment Market Size by Application (2015-2020)
5.2 Global Communicable Diseases Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Communicable Diseases Treatment Market Size (2015-2020)
6.2 Communicable Diseases Treatment Key Players in North America (2019-2020)
6.3 North America Communicable Diseases Treatment Market Size by Type (2015-2020)
6.4 North America Communicable Diseases Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Communicable Diseases Treatment Market Size (2015-2020)
7.2 Communicable Diseases Treatment Key Players in Europe (2019-2020)
7.3 Europe Communicable Diseases Treatment Market Size by Type (2015-2020)
7.4 Europe Communicable Diseases Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Communicable Diseases Treatment Market Size (2015-2020)
8.2 Communicable Diseases Treatment Key Players in China (2019-2020)
8.3 China Communicable Diseases Treatment Market Size by Type (2015-2020)
8.4 China Communicable Diseases Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Communicable Diseases Treatment Market Size (2015-2020)
9.2 Communicable Diseases Treatment Key Players in Japan (2019-2020)
9.3 Japan Communicable Diseases Treatment Market Size by Type (2015-2020)
9.4 Japan Communicable Diseases Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Communicable Diseases Treatment Market Size (2015-2020)
10.2 Communicable Diseases Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Communicable Diseases Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Communicable Diseases Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Communicable Diseases Treatment Market Size (2015-2020)
11.2 Communicable Diseases Treatment Key Players in India (2019-2020)
11.3 India Communicable Diseases Treatment Market Size by Type (2015-2020)
11.4 India Communicable Diseases Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Communicable Diseases Treatment Market Size (2015-2020)
12.2 Communicable Diseases Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Communicable Diseases Treatment Market Size by Type (2015-2020)
12.4 Central & South America Communicable Diseases Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis
  13.1.1 Novartis Company Details
  13.1.2 Novartis Business Overview and Its Total Revenue
  13.1.3 Novartis Communicable Diseases Treatment Introduction
  13.1.4 Novartis Revenue in Communicable Diseases Treatment Business (2015-2020))
  13.1.5 Novartis Recent Development
13.2 Gilead
  13.2.1 Gilead Company Details
  13.2.2 Gilead Business Overview and Its Total Revenue
  13.2.3 Gilead Communicable Diseases Treatment Introduction
  13.2.4 Gilead Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.2.5 Gilead Recent Development
13.3 GSK
  13.3.1 GSK Company Details
  13.3.2 GSK Business Overview and Its Total Revenue
  13.3.3 GSK Communicable Diseases Treatment Introduction
  13.3.4 GSK Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.3.5 GSK Recent Development
13.4 Janssen Pharmaceutical
  13.4.1 Janssen Pharmaceutical Company Details
  13.4.2 Janssen Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Janssen Pharmaceutical Communicable Diseases Treatment Introduction
  13.4.4 Janssen Pharmaceutical Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.4.5 Janssen Pharmaceutical Recent Development
13.5 Roche
  13.5.1 Roche Company Details
  13.5.2 Roche Business Overview and Its Total Revenue
  13.5.3 Roche Communicable Diseases Treatment Introduction
  13.5.4 Roche Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.5.5 Roche Recent Development
13.6 BioCryst Pharmaceuticals
  13.6.1 BioCryst Pharmaceuticals Company Details
  13.6.2 BioCryst Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 BioCryst Pharmaceuticals Communicable Diseases Treatment Introduction
  13.6.4 BioCryst Pharmaceuticals Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.6.5 BioCryst Pharmaceuticals Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Communicable Diseases Treatment Introduction
  13.7.4 Merck Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Boehringer Ingelheim
  13.8.1 Boehringer Ingelheim Company Details
  13.8.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.8.3 Boehringer Ingelheim Communicable Diseases Treatment Introduction
  13.8.4 Boehringer Ingelheim Revenue in Communicable Diseases Treatment Business (2015-2020)
  13.8.5 Boehringer Ingelheim Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Communicable Diseases Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Communicable Diseases Treatment Revenue
Table 3. Ranking of Global Top Communicable Diseases Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Communicable Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HIV
Table 6. Key Players of Influenza
Table 7. Key Players of TB
Table 8. Key Players of Malaria
Table 9. Key Players of Hepatitis
Table 10. Key Players of HPV
Table 11. Global Communicable Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Communicable Diseases Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Communicable Diseases Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Communicable Diseases Treatment Market Share by Regions (2015-2020)
Table 15. Global Communicable Diseases Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Communicable Diseases Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Communicable Diseases Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Communicable Diseases Treatment Players
Table 22. Global Communicable Diseases Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Communicable Diseases Treatment Market Share by Players (2015-2020)
Table 24. Global Top Communicable Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Communicable Diseases Treatment as of 2019)
Table 25. Global Communicable Diseases Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Communicable Diseases Treatment Product Solution and Service
Table 28. Date of Enter into Communicable Diseases Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Communicable Diseases Treatment Market Size Share by Type (2015-2020)
Table 32. Global Communicable Diseases Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Communicable Diseases Treatment Market Size Share by Application (2015-2020)
Table 34. Global Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Communicable Diseases Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 38. North America Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 40. North America Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 44. Europe Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 46. Europe Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 50. China Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 52. China Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 56. Japan Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 58. Japan Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 62. Southeast Asia Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 68. India Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 70. India Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Communicable Diseases Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Communicable Diseases Treatment Market Share (2019-2020)
Table 74. Central & South America Communicable Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Communicable Diseases Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Communicable Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Communicable Diseases Treatment Market Share by Application (2015-2020)
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Product
Table 81. Novartis Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 82. Novartis Recent Development
Table 83. Gilead Company Details
Table 84. Gilead Business Overview
Table 85. Gilead Product
Table 86. Gilead Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 87. Gilead Recent Development
Table 88. GSK Company Details
Table 89. GSK Business Overview
Table 90. GSK Product
Table 91. GSK Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 92. GSK Recent Development
Table 93. Janssen Pharmaceutical Company Details
Table 94. Janssen Pharmaceutical Business Overview
Table 95. Janssen Pharmaceutical Product
Table 96. Janssen Pharmaceutical Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 97. Janssen Pharmaceutical Recent Development
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Product
Table 101. Roche Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 102. Roche Recent Development
Table 103. BioCryst Pharmaceuticals Company Details
Table 104. BioCryst Pharmaceuticals Business Overview
Table 105. BioCryst Pharmaceuticals Product
Table 106. BioCryst Pharmaceuticals Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 107. BioCryst Pharmaceuticals Recent Development
Table 108. Merck Company Details
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 112. Merck Recent Development
Table 113. Boehringer Ingelheim Business Overview
Table 114. Boehringer Ingelheim Product
Table 115. Boehringer Ingelheim Company Details
Table 116. Boehringer Ingelheim Revenue in Communicable Diseases Treatment Business (2015-2020) (Million US$)
Table 117. Boehringer Ingelheim Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Communicable Diseases Treatment Market Share by Type: 2020 VS 2026
Figure 2. HIV Features
Figure 3. Influenza Features
Figure 4. TB Features
Figure 5. Malaria Features
Figure 6. Hepatitis Features
Figure 7. HPV Features
Figure 8. Global Communicable Diseases Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Communicable Diseases Treatment Report Years Considered
Figure 13. Global Communicable Diseases Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Communicable Diseases Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Communicable Diseases Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Communicable Diseases Treatment Market Share by Players in 2019
Figure 18. Global Top Communicable Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Communicable Diseases Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Communicable Diseases Treatment Revenue in 2019
Figure 20. North America Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Communicable Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 29. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Gilead Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 31. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GSK Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 33. Janssen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Janssen Pharmaceutical Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 37. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. BioCryst Pharmaceuticals Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 41. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Boehringer Ingelheim Revenue Growth Rate in Communicable Diseases Treatment Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed